Zoetis ZTS
NYSE ZTS
$73.31 -0.25 (-0.34%)
As of: Sep 9, 2026 · 3:59 PM EDT

Zoetis (ZTS) Cash from Financing Activities (2012 - 2026)

Zoetis' (ZTS) quarterly Cash from Financing Activities came in at -$813.0 million in Q2 2026, down 44.15% year-over-year from -$1.5 billion in Q2 2025, and up 3.21% quarter-over-quarter from -$840.0 million in Q1 2026.

Analysis

Zoetis (ZTS) Cash from Financing Activities (2012 - 2026) Analysis & Trends

Zoetis (ZTS) has reported Cash from Financing Activities for 15 consecutive years, with -$813.0 million the latest figure, recorded in Q2 2026.

  • On a quarterly basis, Cash from Financing Activities fell 44.15% year-over-year to -$813.0 million in Q2 2026; TTM through Jun 2026 was -$2.3 billion, a 12.7% increase from a year earlier, with the FY2025 full-year figure at -$1.9 billion, up 29.7% from the prior year.
  • Cash from Financing Activities was -$813.0 million for Q2 2026 at Zoetis, up from -$840.0 million in the prior quarter.
  • Over five years, Cash from Financing Activities peaked at $780.0 million in Q4 2022 and troughed at -$1.8 billion in Q1 2023.
  • A 5-year average of -$566.4 million and a median of -$554.5 million in 2022 frame the typical range for Cash from Financing Activities.
  • Across the five-year window, Cash from Financing Activities jumped 348.41% in 2022 and slumped 230.64% in 2023, its largest moves.
  • Over 5 years, Cash from Financing Activities stood at $780.0 million in 2022, then sank by 150.9% to -$397.0 million in 2023, then slumped by 87.66% to -$745.0 million in 2024, then jumped by 33.56% to -$495.0 million in 2025, then plunged by 64.24% to -$813.0 million in 2026.
  • The last three Cash from Financing Activities figures came in at -$813.0 million (Q2 2026), -$840.0 million (Q1 2026), and -$495.0 million (Q4 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Financing Activities (Qtr)
1 Idexx Laboratories 40.69 Bn 40.49 Bn 779.09 Mn -325.19 Mn
2 Zoetis 30.63 Bn 28.95 Bn 1.05 Bn -813.00 Mn
3 Elanco Animal Health 11.77 Bn 11.24 Bn 798.00 Mn -74.00 Mn
4 Phibro Animal Health 1.49 Bn 1.41 Bn 134.40 Mn -1.62 Mn
5 Immucell 90.19 Mn 81.33 Mn 2.44 Mn -
6 Zhengye Biotechnology Holding 76.23 Mn 69.14 Mn - -
7 Global Innovative Platforms 24.88 Mn 24.63 Mn - 105,646.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -813.00 Mn
Mar 31, 2026 -840.00 Mn
Dec 31, 2025 -495.00 Mn
Sep 30, 2025 -134.00 Mn
Jun 30, 2025 -564.00 Mn
Mar 31, 2025 -677.00 Mn
Dec 31, 2024 -745.00 Mn
Sep 30, 2024 -628.00 Mn
Jun 30, 2024 -763.00 Mn
Mar 31, 2024 -524.00 Mn
Dec 31, 2023 -397.00 Mn
Sep 30, 2023 -416.00 Mn
Jun 30, 2023 -494.00 Mn
Mar 31, 2023 -1.80 Bn
Dec 31, 2022 780.00 Mn
Sep 30, 2022 -529.00 Mn
Jun 30, 2022 -610.00 Mn
Mar 31, 2022 -545.00 Mn
Dec 31, 2021 -314.00 Mn
Sep 30, 2021 -919.00 Mn